| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/03/2002 | US6444434 Compounds inhibiting the activation of fx to fxa by tf/fviia. the compounds are anticoagulants. the invention also relates to a method of identifying a drug candidate. |
| 09/03/2002 | US6444208 Ribonuclease III from Streptococcus pneumoniae |
| 09/03/2002 | US6444206 Sepsis therapy; monoclonal antibodies |
| 09/03/2002 | CA2263203C 3,6-ketal and enol ether macrolide antibiotics |
| 09/03/2002 | CA2258960C A process for preparing naphthyridones and intermediates |
| 09/03/2002 | CA2160764C Fish pancreatic disease virus |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/03/2002 | CA2093557C Antimicrobial composition |
| 08/29/2002 | WO2002066979A1 Method of detecting antigen causative of bronchial asthma |
| 08/29/2002 | WO2002066650A2 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066635A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 08/29/2002 | WO2002066624A2 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | WO2002066621A1 Attenuated live vaccine |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066499A1 Cyclic peptide |
| 08/29/2002 | WO2002066476A1 6-phenylbenzonaphthyridines |
| 08/29/2002 | WO2002066465A1 Water-soluble triazole fungicide |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/29/2002 | WO2002066447A1 4h-1,2,4-triazole-3(2h)-thione deratives as sphingomyelinase inhibitors |
| 08/29/2002 | WO2002066067A2 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 08/29/2002 | WO2002066053A2 Method of treating or preventing disease characterized by cryptococcus neoformans infection |
| 08/29/2002 | WO2002066050A1 Casoase 3 inhibitors |
| 08/29/2002 | WO2002066037A2 Antiviral method of use |
| 08/29/2002 | WO2002066022A1 Retinoid hepatitis therapy |
| 08/29/2002 | WO2002066018A2 Transdermal therapeutic system containing testosterone and method for the production thereof |
| 08/29/2002 | WO2002066016A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
| 08/29/2002 | WO2002065989A2 Aminoglycoside treatment for lysosomal storage diseases |
| 08/29/2002 | WO2002065986A2 Transporters comprising spaced arginine moieties |
| 08/29/2002 | WO2002065979A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 08/29/2002 | WO2002050108A3 Immunogenic glycopeptides, screening, preparation and uses |
| 08/29/2002 | WO2002043649A3 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 08/29/2002 | WO2002042316A3 Pna analogues |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002030930A3 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 08/29/2002 | WO2002028867A3 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 08/29/2002 | WO2002028422A3 Split enveloped virus preparation for intranasal delivery |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002008256A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 08/29/2002 | WO2002008241A3 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 08/29/2002 | WO2002004018A3 Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| 08/29/2002 | WO2002002525A3 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 08/29/2002 | WO2002002141A3 Vaccine against helicobacter pylori |
| 08/29/2002 | WO2002000836A3 Spinigerin variants, an antibacterial and antifungal peptide derived from pseudacanthotermes spiniger, preparation method and compositions containing same |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001041758A8 Valnemulin formulation |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | WO2000059515A9 Immunomodulating polymers |
| 08/29/2002 | WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 08/29/2002 | WO1999057280A9 Neisseria meningitidis antigens and compositions |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120152 Aminoaryl oxazolidinone N-oxides |
| 08/29/2002 | US20020120145 Inhibiting farnesyl protein transferase. |
| 08/29/2002 | US20020120101 Biosurfactants for blocking the interaction of a pathogen with a collagen receptor |
| 08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
| 08/29/2002 | US20020119995 Inverse thiazolylamide derivatives |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119984 Azole compounds as anti-fungal agents |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 08/29/2002 | US20020119961 Bridged piperazine derivatives |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119949 Prophylactic teat treatment |
| 08/29/2002 | US20020119938 Antibiotics |
| 08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
| 08/29/2002 | US20020119562 Method for selecting improved vectors |
| 08/29/2002 | US20020119510 Enzymatic polypeptide for use in screening bactericides |
| 08/29/2002 | US20020119445 Genetic engineering; prophylactic therapy |
| 08/29/2002 | US20020119443 Screening preferential prodrugs for use in viral therapy; obtain target tissue, incubate with prodrug, monitor and evaluate prodrug activity in tissues |
| 08/29/2002 | US20020119207 For decontaminating areas, samples, solutions, and foodstuffs colonized or otherwise infected by pathogens and microorganisms |
| 08/29/2002 | US20020119206 Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions |
| 08/29/2002 | US20020119198 For manufacture of a medicament for therapeutic treatment, such as steroidal, antifungal, antibacterial, or anticancer treatment |
| 08/29/2002 | US20020119165 Peptides for inhibition of herpes simplex virus entry |
| 08/29/2002 | US20020119164 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 08/29/2002 | US20020119161 Contacting Bordetella pertussis culture into with calcium phosphate gel for separating pertussis filamentous hemagglutinin (FHA), pertactin (PRN, 69K-OMP), pertussis fimbriae (FIM), and pertussis toxin |
| 08/29/2002 | US20020119143 Antithrombin III for disorders caused by angiogenesis |
| 08/29/2002 | US20020119136 Antimicrobial peroxidase compositions |
| 08/29/2002 | US20020119121 Compositions and methods for inducing specific cytolytic T cell responses |
| 08/29/2002 | DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 08/29/2002 | CA2476397A1 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | CA2473197A1 Novel human protease and polynucleotides encoding the same |
| 08/29/2002 | CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy |
| 08/29/2002 | CA2439193A1 Casoase 3 inhibitors |
| 08/29/2002 | CA2438750A1 Aminoglycoside treatment for lysosomal storage diseases |
| 08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2437168A1 Retinoid hepatitis therapy |
| 08/29/2002 | CA2434648A1 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 08/29/2002 | CA2432929A1 Antiviral method of use |
| 08/28/2002 | EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234816A1 Scyphostatin analogues as SMase inhibitors |
| 08/28/2002 | EP1234584A1 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption |
| 08/28/2002 | EP1234580A1 Acellular Pertussis Vaccines and Methods of Preparation Thereof |